193 related articles for article (PubMed ID: 32240715)
1. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
Boon D; Bruce V; Patel EU; Quinn J; Srikrishnan AK; Shanmugam S; Iqbal S; Balakrishnan P; Sievers M; Kirk GD; Thomas DL; Quinn TC; Cox AL; Page KA; Solomon SS; Mehta SH; Laeyendecker O
J Hepatol; 2020 Aug; 73(2):294-302. PubMed ID: 32240715
[TBL] [Abstract][Full Text] [Related]
2. Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.
Patel EU; Cox AL; Mehta SH; Boon D; Mullis CE; Astemborski J; Osburn WO; Quinn J; Redd AD; Kirk GD; Thomas DL; Quinn TC; Laeyendecker O
J Infect Dis; 2016 Aug; 214(3):344-52. PubMed ID: 26768250
[TBL] [Abstract][Full Text] [Related]
3. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
[TBL] [Abstract][Full Text] [Related]
4. HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype.
Shepherd SJ; McDonald SA; Palmateer NE; Gunson RN; Aitken C; Dore GJ; Goldberg DJ; Applegate TL; Lloyd AR; Hajarizadeh B; Grebely J; Hutchinson SJ
J Med Virol; 2018 Jan; 90(1):120-130. PubMed ID: 28843002
[TBL] [Abstract][Full Text] [Related]
5. Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spots.
Eshetu A; Hauser A; An der Heiden M; Schmidt D; Meixenberger K; Ross S; Obermeier M; Ehret R; Bock CT; Bartmeyer B; Bremer V; Bannert N
J Immunol Methods; 2020 Apr; 479():112744. PubMed ID: 31958450
[TBL] [Abstract][Full Text] [Related]
6. Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2021 Feb; 74(2):303-311. PubMed ID: 32931878
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic.
Taylor LE; Foont JA; DeLong AK; Wurcel A; Linas BP; Chapman S; Maynard MA; Cu-Uvin S; Mayer KH
AIDS Patient Care STDS; 2014 Jan; 28(1):4-9. PubMed ID: 24428794
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
Kanno A; Kazuyama Y
J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
[TBL] [Abstract][Full Text] [Related]
10. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.
Taylor LE; Holubar M; Wu K; Bosch RJ; Wyles DL; Davis JA; Mayer KH; Sherman KE; Tashima KT
Clin Infect Dis; 2011 Mar; 52(6):812-8. PubMed ID: 21282184
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.
Boettiger DC; Law MG; Dore GJ; Guy R; Callander D; Donovan B; O'Connor CC; Fairley CK; Hellard M; Matthews G
BMC Infect Dis; 2017 Dec; 17(1):740. PubMed ID: 29191154
[TBL] [Abstract][Full Text] [Related]
12. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
13. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
[TBL] [Abstract][Full Text] [Related]
14. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.
Bonacini M; Lin HJ; Hollinger FB
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):340-4. PubMed ID: 11317075
[TBL] [Abstract][Full Text] [Related]
15. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
[TBL] [Abstract][Full Text] [Related]
16. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.
Beld M; Penning M; van Putten M; van den Hoek A; Damen M; Klein MR; Goudsmit J
Blood; 1999 Aug; 94(4):1183-91. PubMed ID: 10438705
[TBL] [Abstract][Full Text] [Related]
17. Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men.
Medland NA; Chow EP; Bradshaw CS; Read TH; Sasadeusz JJ; Fairley CK
BMC Infect Dis; 2017 Mar; 17(1):185. PubMed ID: 28253838
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis E Infection in a Longitudinal Cohort of Hepatitis C Virus and HCV/HIV Coinfected Persons.
Sherman KE; Kottilil S; Rouster SD; Abdel-Hameed EA; Boyce CL; Meeds HL; Terrault N; Shata MT
AIDS Res Hum Retroviruses; 2021 Jul; 37(7):534-541. PubMed ID: 33794657
[TBL] [Abstract][Full Text] [Related]
19. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
